Oxford BioMedica has signed a deal worth up to $100m with Novartis to supply modified viruses used to generate its CAR-T therapies. The deal represents a major financial boost for the UK biotech ...

Gene and cell therapy specialist Oxford Biomedica has signed a one-year agreement with AstraZeneca to manufacture the potential COVID-19 vaccine in development in partnership with Oxford ...

Oxford BioMedica (GB:OXB) has released an update. Oxford Biomedica has announced the granting of nil-cost share options under its 2024 Long ...

Oxford BioMedica (GB:OXB) has released an update. Oxford Biomedica, a leader in cell and gene therapy, announced a total of 105,923,083 voting ...

Oxford Biomedica maintained its 2024 earnings outlook after reporting strong revenue growth in the first half of the year.

Storia di un femminicidio: il caso di Giulia CecchettinNel novembre 2023, il femminicidio di Giulia Cecchettin ha scosso ...

Gli studenti possono scegliere tra diverse specializzazioni: Bioelettronica, Bioimaging, Fisica medica e Bioingegneria molecolare. In consultazione con il consulente agli studi, tutte le materie ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Oxford Biomedica is listed on the Aquis Stock Exchange trading with ticker code OXB.GB.PL. It has a market capitalisation of £426.63m, with approximately 105.34m shares in issue. Over the last ...

AHK Italien e B. Braun insieme per l'innovazione biomedica Bce, terzo taglio: il tasso sui depositi scende di altri 25 punti base al 3,25%. Gli effetti Malattia del vampiro, diagnosi a ragazza ...